TQB-3728

N/A

Report date: 2023/05/17 20:00:39
NME

Base Information

Drug NameTQB-3728
Drug Alias NameTQB-3728
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActioncIAP1/cIAP2 inhibitorsInhibitor of apoptosis protein 3 inhibitors
TargetsInhibitor of apoptosis protein 3cIAP1/cIAP2
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungHematologic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungHematologic Neoplasms +[4] 
Inactive IndicationsHead and Neck Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A